Mutations in the cystic fibrosis transmembrane regulator gene in patients with tropical calcific pancreatitis.
Mutations in the cystic fibrosis transmembrane regulator gene in patients with tropical calcific pancreatitis.
复制标题
热带钙化性胰腺炎患者囊性纤维化跨膜调节基因的突变。
DOI:
10.1111/j.1572-0241.2000.03400.x
复制
发表时间:
2000
期刊:
影响因子:
--
通讯作者:
Tsui,LC
中科院分区:
文献类型:
--
作者:
Bhatia,E;Durie,P;Zielenski,J;Lam,D;Sikora,SS;Choudhuri,G;Tsui,LC
TO THE EDITOR: Tropical calcific pancreatitis (TCP), a form of chronic pancreatitis of unknown etiology, is unique to developing countries in tropical regions of the world (1). Patients with TCP present at a young age with severe abdominal pain and insulin-requiring diabetes. A history of alcohol abuse is absent, as are other commonly known etiological factors for chronic pancreatitis. In view of evidence of familial clustering of TCP, genetic susceptibility may play a role in its etiology. Analysis of two candidate genes, the reg 1A gene and the cationic trypsinogen gene, have revealed no sequence abnormalities in DNA from affected patients.Recurrent acute and chronic pancreatitis is known to occur in a subset of classically diagnosed patients with cystic fibrosis (CF) who have pancreatic sufficiency (2). More recently, a higher frequency of mutations in the cystic fibrosis transmembrane regulator (CFTR) gene have been found in white Caucasian patients with idiopathic chronic pancreatitis, in comparison to the general population (3, 4). Most of these patients lacked other classical features of CF, consistent with previous observations in infertile men with obstructive azoospermia, many of whom carry CFTR gene mutations on one or both alleles (5). The aim of the present